Table 3.
Linear B-cell epitope, antigenic regions, and surface accessible epitopes predicted from the conserved region of nucleoprotein (NP).
| Peptide | Length |
|---|---|
| BepiPred analysis (linear B-cell epitope) | |
| SSGKN | 5 |
| AMPEEETTEANA | 12 |
| TAWQ | 4 |
| HDANDAV | 7 |
| KVKN | 4 |
| KHGEYA | 6 |
| AHGS | 4 |
| VGEQYQQLREAATEAEKQLQQYAESR | 26 |
| LDDQ | 4 |
| EISF | 4 |
|
| |
| IEDB analysis (antigenic sites) | |
| KRLEELLPAVSSG | 13 |
| GQFLSFASLFLPKLVVGEKACLEK | 55 |
| VQRQIQVHAEQGLIQYPTAWQSV | |
| GHMMVIFR | |
| LIKFLLIHQ | 9 |
| NDAVISNSVAQA | 12 |
| FSGLLIVKTVLDHILQ | 16 |
| GVRLHPLARTA | 11 |
| SFKAALSSLAKHGEYAPFARLLNLS | 25 |
| HGLFPQLSAIALGVATA | 17 |
| GSTLAGVNVGEQYQQLRE | 18 |
| LDHLGL | 6 |
|
| |
| Surface accessible epitope | |
| MPEEETTE | 8 |
| AKVKNE | 6 |
| GEQYQQLR | 8 |
| AATEAEKQLQQYAESREL | 18 |
| FHQKKNE | 7 |
| LRKERL | 6 |